According to TechSci Research report, Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the global clot management devices market is anticipated to grow at an impressive rate during the forecast period, 2024-2028This can be ascribed to the increasing coronary heart disease, periphery arterial diseases, stroke and venous thromboembolism is further expected to increase the demand for clot management devices. Similarly, increasing geriatric population, increasing demand for effective thrombectomy or embolectomy devices and increasing awareness regarding newer approaches for clot management device, and growing awareness of using clot management device amongst the patient and healthcare professionals across the world is expected to drive global clot management devices market during the forecast period.

However, reimbursement procedures are not well defined in many developing countries which may restrain the growth of the global clot management devices market during the forecast period. Additionally, high cost of clot management devices and availability of alternative treatments are expected to hamper the overall market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Clot Management Devices Market" -

The global clot management devices market is segmented on the basis of product type, end user, and region.

Based on product type, the global clot management devices market can be fragmented into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter directed thrombolysis devices, and others. Neurovascular embolectomy device type is expected to dominate the market during the forecast period, owing to factors such as increasing investment in the research and development, rising demand for cost effective devices and improvement in patient health outcomes.

Based on region, the global clot management devices market can be further divided into North America, Asia Pacific, Europe, South America and Middle East & Africa. North America region is expected to dominate the market in 2022 and maintain its dominance throughout the forecast period. However, increasing prevalence of brain and heart strokes. Increasing prevalence of cardiovascular and neurological diseases will support the market growth in the forecast period.

Based on end user, the global clot management device market can be further split into hospitals & clinics, ambulatory care centers, and others. Diagnostic centers are expected to dominate the market during the forecast period. Increasing demand for reducing hospital expenses and reduce waiting time for low-risk clot removal are the main factors driving the global clot management devices market during the forecast period.

Major companies operating in global clot management devices market are:

  • Medtronic Plc.
  • Concentric Medical, Inc.
  • Boston Scientific Corporation
  • Edward LifeSciences Corporation
  • AngioDynamics, Inc.
  • LeMaitre Vascular, Inc.
  • Teleflex Incorporated
  • Johnson & Johnson
  • Strub Medical GmbH & Co. KG
  • Cook Group Incorporated

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Asia Pacific is expected to register the highest growth in the global clot management devices market on account increasing obesity, diabetes, and cardiovascular disease due to change in lifestyle, increase in disposable income in countries such as China and India. Similarly, increasing prevalence of targeted diseases coupled with improvement in healthcare infrastructure and development of technologically advanced products is further expected to support the market growth. Additionally, a huge number of individuals are suffering from heart ailments, Deep Vein Thrombosis and Pulmonary Embolism, which is expected to drive market growth during the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition”, has evaluated the future growth potential of global clot management devices market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global clot management devices market.

Download Free Sample Report -

Related Reports:

Cell banking outsourcing market

Preimplantation genetic testing market

Viral non viral vector manufacturing market

United kingdom dental bone graft substitute market

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]